Jiksak Bioengineering is a biotechnology company.
Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 23, 2021 | Series B | — | 1 | CEJ Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
CEJ Capital | Yes | Series B |